Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 89 years old
- You have been diagnosed with a primary muscle disease, confirmed through genetic testing, blood tests, or a previous muscle biopsy
Who may not be able to join:
- You are unable to lie flat or have a history of claustrophobia (fear of enclosed spaces)
- You have more than mild swelling in your lower legs or feet
- You have several other conditions (besides the muscle disease being studied) that affect the muscles in your lower legs
- You are pregnant
- You have a medical device or implant that is not safe for MRI scans, such as certain pacemakers, deep brain stimulators, or metal hardware in your lower limbs
- You have had a scan using a radioactive tracer in the past 15 days
- You have had an imaging scan using contrast dye in the past 7 days
- You weigh more than 450 pounds
- You have taken calcium supplements or antacids containing calcium in the past 24 hours
- Your BMI (body mass index) is above 35, due to difficulties with MRI scanning and the effect this may have on test results
- You have a long-term skin condition with open sores on your skin that could interfere with or make uncomfortable the use of small electrode patches on your skin (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathology-specific penalized regression development. Predictive algorithms connecting EIM data sets to MRI outcomes representative of muscle pathology, including muscle cross-sectional area, fat content, edema, and fiber disorganization.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.